newsfilter
← Latest News
Business Wire·

enGene Reports Third Quarter 2025 Financial Results and Provides Business Update

Achieved target enrollment milestone for LEGEND trial pivotal cohort in high-risk BCG unresponsive NMIBC with carcinoma in situ LEGEND's pivotal cohort data update planned for 4Q 2025 Detalimogene granted